biochem pharma one canadas largest biotechnology companies taking drug developing glaxo europes biggest pharmaceutical company last stage clinical trials writes daniel green trials far shown lamivudine far superior existing treatments hepatitis b said dr francesco bellini president montreal company hoping launch drug 1997 the deal glaxo gives uk company marketing rights outside north america joint venture operating canada biochem selling alone us